Sigma1R Protein
Overview <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Sigma1R Protein</th> </tr> <tr> <td class="label">Drug</td> <td>Mechanism</td> </tr> <tr> <td class="label">Preladenant</td> <td>A₂A antagonist/Sigma1R modulator</td> </tr> <tr> <td class="label">SA4503</td> <td>Sigma1R agonist</td> </tr> <tr> <td class="label">[Donepezil](/entities/donepezil)</td> <td>Sigma1R binding</td> </tr> <tr> <td class="label">Fluvoxamine</td> <td>Sigma1R agonist</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">IP₃R</td> <td>Ca²⁺ channel modulation</td> </tr> <tr> <td class="label">VDAC</td> <td>Ion channel</td> </tr> <tr> <td class="label">BiP</td> <td>Chaperone complex</td> </tr> <tr> <td class="label">Grp94</td> <td>Chaperone</td> </tr> <tr> <td class="label">Sigmat</td> <td>Hetodimer formation</td> </tr> <tr> <td class="label">TDP-43</td> <td>Aggregation</td> </tr> <tr> <td class="label">mHTT</td> <td>Aggregate interaction</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
...
Sigma1R Protein
Overview <table class="infobox infobox-protein"> <tr> <th class="infobox-header" colspan="2">Sigma1R Protein</th> </tr> <tr> <td class="label">Drug</td> <td>Mechanism</td> </tr> <tr> <td class="label">Preladenant</td> <td>A₂A antagonist/Sigma1R modulator</td> </tr> <tr> <td class="label">SA4503</td> <td>Sigma1R agonist</td> </tr> <tr> <td class="label">[Donepezil](/entities/donepezil)</td> <td>Sigma1R binding</td> </tr> <tr> <td class="label">Fluvoxamine</td> <td>Sigma1R agonist</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">IP₃R</td> <td>Ca²⁺ channel modulation</td> </tr> <tr> <td class="label">VDAC</td> <td>Ion channel</td> </tr> <tr> <td class="label">BiP</td> <td>Chaperone complex</td> </tr> <tr> <td class="label">Grp94</td> <td>Chaperone</td> </tr> <tr> <td class="label">Sigmat</td> <td>Hetodimer formation</td> </tr> <tr> <td class="label">TDP-43</td> <td>Aggregation</td> </tr> <tr> <td class="label">mHTT</td> <td>Aggregate interaction</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Sigma1 receptor 1 (Sigma1R) is a unique ER-resident chaperone protein that functions as a ligand-operated molecular chaperone. It plays critical roles in calcium signaling, lipid metabolism, and protein quality control. Sigma1R has emerged as a significant therapeutic target in neurodegenerative diseases including ALS, AD, PD, and Huntington's disease due to its involvement in ER stress response, mitochondrial function, and neuroprotection.
Structure
Primary Structure
Length: 223 amino acids
Molecular Weight: ~25,340 Da
Topology: Single-pass membrane protein (type I)
Domain Architecture
N-terminal ER Luminal Domain: Residues 1-180
Contains the chaperone domain
Ligand-binding pocket
C-terminal ER Retention Signal: KDEL motif (residues 220-223)
Structural Features
Trimeric Assembly: Forms functional trimers
Ligand-Binding Site: Hydrophobic pocket in luminal domain
Ca²⁺ Binding: Regulatory Ca²⁺-binding site
Key Mutations
D91G: Juvenile ALS, loss of function
L95frameshift: ALS, truncated protein
E102Q: ALS, impaired chaperone activity
Normal Function
Molecular Chaperone Activity Sigma1R acts as a ligand-operated chaperone that: [@smith2022]
Stabilizes protein conformations
Prevents aggregation of misfolded proteins
Assists in ER-associated protein quality control
Calcium Signaling
ER-Mitochondria Tethering: Forms mitochondria-associated ER membranes (MAM) complexes
Ca²⁺ Transfer: Regulates Ca²⁺ flux from ER to mitochondria
IP₃R Modulation: Interacts with IP₃ receptors
Sterol Transport: Involved in cholesterol homeostasis
Lipid Raft Organization: Modulates membrane lipid composition
Phospholipid Synthesis: Influences phospholipid metabolism
Additional Functions
Neuroprotection: Reduces oxidative stress
Angiogenesis: Promotes blood vessel formation
Cell Proliferation: Regulates cell cycle
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
ER Stress: Sigma1R mutations cause chronic ER stress
Mitochondrial Dysfunction: Impaired Ca²⁺ transfer to mitochondria
Motor Neuron Degeneration: Loss of proteostasis
Aggregates: Co-localization with [TDP-43](/mechanisms/tdp-43-proteinopathy) inclusions
Alzheimer's Disease
[APP](/entities/app-protein) Processing: Modulates β- and [γ-secretase](/entities/gamma-secretase) activity
[Aβ](/proteins/amyloid-beta) Toxicity: Protects against Aβ-induced neurotoxicity
Calcium Dysregulation: Restores Ca²⁺ homeostasis
Synaptic Function: Preserves synaptic plasticity
Parkinson's Disease
[α-Synuclein](/proteins/alpha-synuclein): Interacts with α-synuclein aggregates
Mitochondrial Protection: Maintains mitochondrial function
Dopaminergic [Neurons](/entities/neurons): Protects against degeneration
Huntington's Disease
Mutant [Huntingtin](/proteins/huntingtin): Interacts with mHTT aggregates
Transcription Regulation: Modulates gene expression
ER Stress: Alleviates ER stress in HD models
Mechanism of Neurodegeneration
Loss of Chaperone Function: Mutant Sigma1R fails to handle protein aggregates
Mitochondrial Calcium Dysregulation: Impaired energy metabolism
ER Stress: Chronic [UPR](/entities/unfolded-protein-response) activation
Oxidative Stress: Increased [ROS](/entities/reactive-oxygen-species) production
Synaptic Dysfunction: Impaired neurotransmission
Therapeutic Targeting
Sigma1R Agonists
Sigma1R Antagonists
NE-100: Selective antagonist, preclinical
BD-1063: Sigma1R antagonist, neuroprotection research
Clinical Trials
NCT05663437: Sigma1R agonists in ALS (recruiting)
NCT05308901: Sigma1R modulators in AD (Phase 2)
Novel Therapeutics
Small Molecule Modulators: Precision medicine approaches
Gene Therapy: AAV-delivered Sigma1R
Protein Replacement: Recombinant Sigma1R
Protein Interactions
Cross-Links
[SIGMAR1 Gene](/genes/sigmar1)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[ER Stress Pathway](/mechanisms/er-stress-pathway)
[Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
See Also
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[ER Stress Pathway](/mechanisms/er-stress-pathway)
[Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Mavlyutov et al., Sigma1R in ALS pathogenesis (2023) (2023)](https://doi.org/10.1016/j.neurobiol.2023.01.012)
[Smith et al., Sigma1R agonists for neurodegeneration (2022) (2022)](https://doi.org/10.1111/bph.15842)
[Onochie et al., Sigma1R and calcium signaling (2022) (2022)](https://doi.org/10.1113/JP282327)
[Penke et al., Sigma1R in Alzheimer's disease (2021) (2021)](https://doi.org/10.3233/JAD-210600)
[Tsai et al., Sigma1R chaperone function (2020) (2020)](https://doi.org/10.1016/j.tcb.2020.01.007)
[Ryskamp et al., Sigma1R and ER stress (2019) (2019)](https://doi.org/10.1111/jnc.14811)
Show full description